MPI Research is pleased to announce that Dr. David Gauvin is the newest Senior Study Director in Safety Pharmacology. Prior to arriving at MPI, Dr. Gauvin served as a Drug Science Officer at the Drug Enforcement Administration in Washington, D.C. In his position at DEA, Dr. Gauvin regularly provided scientific background, briefings and advised a number of federal agencies involved in national and international drug control policy. Previously, Dr. Gauvin conducted drug abuse-related research for 11 years as a Research Professor in the Department of Psychiatry & Behavioral Sciences at the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma. His research has spanned a diverse range of topics in psychopharmacology, and he has published over 100 research articles, book chapters, and abstracts on topics related to the preclinical screening of drugs of abuse.

Dr. Gauvin received his bachelor’s degree in psychology from the University of Michigan in 1982, and his Master’s and Doctoral Degrees in psychopharmacology from Wayne State University in Detroit, Michigan in 1986 and 1987, respectively. He completed a three-year NIAAA funded post-doctoral training fellowship in psychopharmacology at the University of Oklahoma prior to his faculty appointment there. Dr. Gauvin won numerous research and teaching awards while at the University of Oklahoma. In 2002, he received one of law enforcement’s highest honors, the DEA’s Administrator’s Award, for his work on the regulatory control of marijuana.

Dr. James Laveglia, Executive Vice President and Director of Research, commented, “We are honored to have Dr. David Gauvin as part of the Scientific Research Team. His specialized experience will provide leadership to our Safety Pharmacology team as well as offer guidance to our Sponsors on their research programs.”

MPI Research exists to provide comprehensive non-clinical research that meets the requirements of pharmaceutical, medical device, animal health and chemical companies as well as governmental agencies as we partner together to bring safer, healthier products to the world. MPI Research employees specialize in a wide variety of scientific disciplines including toxicology, pharmacology, metabolism, pathology, clinical pathology, reproductive and developmental biology, veterinary science, neuroscience, experimental therapeutics, immunotoxicology, analytical chemistry, computer science, regulatory science, and statistics.

Home | News